Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Suzuki, N. Kadota, Tomokazu Hara, Y. Nakagami, T. Izumi, T. Takenawa, H. Sabe, T. Endo (2000)
Meltrin α cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-SrcOncogene, 19
J. White (2003)
ADAMs: modulators of cell-cell and cell-matrix interactions.Current opinion in cell biology, 15 5
I. Kärkkäinen, R. Karhu, A. Huovila (2000)
Assignment1 of the ADAM15 gene to human chromosome band 1q21.3 by in situ hybridizationCytogenetic and Genome Research, 88
Barbara Herren, E. Raines, R. Ross (1997)
Expression of a disintegrin‐like protein in cultured human vascular cells and in vivoThe FASEB Journal, 11
M. Fogel, P. Gutwein, S. Mechtersheimer, S. Riedle, Alexander Stoeck, A. Smirnov, L. Edler, A. Ben‐arie, M. Huszar, P. Altevogt (2003)
L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomasThe Lancet, 362
M. Waltz, S. Pandelidis, W. Pratt, D. Barnes, D. Swallow, S. Gendler, E. Cohen (1998)
A microsatellite within the MUC1 locus at 1q21 is altered in the neoplastic cells of breast cancer patients.Cancer genetics and cytogenetics, 100 1
Eiichi Shimizu, A. Yasui, K. Matsuura, N. Hijiya, Y. Higuchi, Shunsuke Yamamoto (2003)
Structure and expression of the murine ADAM 15 gene and its splice variants, and difference of interaction between their cytoplasmic domains and Src family proteins.Biochemical and biophysical research communications, 309 4
Zaruhi Poghosyan, S. Robbins, M. Houslay, A. Webster, G. Murphy, D. Edwards (2002)
Phosphorylation-dependent Interactions between ADAM15 Cytoplasmic Domain and Src Family Protein-tyrosine Kinases*The Journal of Biological Chemistry, 277
C. O'Shea, N. Mckie, Y. Buggy, C. Duggan, A. Hill, E. McDermott, N. O’higgins, M. Duffy (2003)
Expression of ADAM‐9 mRNA and protein in human breast cancerInternational Journal of Cancer, 105
M. Galliano, Clotilde Huet, J. Frygelius, Anna Polgren, U. Wewer, E. Engvall (2000)
Binding of ADAM12, a Marker of Skeletal Muscle Regeneration, to the Muscle-specific Actin-binding Protein, α-Actinin-2, Is Required for Myoblast Fusion*The Journal of Biological Chemistry, 275
(2003)
PACSIN3 binds ADAM12/meltrin alpha
J. Krätzschmar, L. Lum, C. Blobel (1996)
Metargidin, a Membrane-anchored Metalloprotease-Disintegrin Protein with an RGD Integrin Binding Sequence (*)The Journal of Biological Chemistry, 271
T. Harada, A. Nishie, K. Torigoe, K. Ikezaki, T. Shono, Y. Maehara, M. Kuwano, M. Wada (2000)
The Specific Expression of Three Novel Splice Variant Forms of Human Metalloprotease‐like Disintegrin‐like Cysteine‐rich Protein 2 Gene in Brain Tissues and GliomaJapanese Journal of Cancer Research : Gann, 91
K. Horiuchi, G. Weskamp, L. Lum, H. Hammes, H. Cai, T. Brodie, T. Ludwig, R. Chiusaroli, R. Baron, K. Preissner, K. Manova, C. Blobel (2003)
Potential Role for ADAM15 in Pathological Neovascularization in MiceMolecular and Cellular Biology, 23
Hélène Pabic, D. Bonnier, U. Wewer, A. Coutand, O. Musso, G. Baffet, B. Clement, N. Théret (2003)
ADAM12 in human liver cancers: TGF‐β‐regulated expression in stellate cells is associated with matrix remodelingHepatology, 37
Blobel (2002)
Functional and biochemical characterization of ADAMs and their predicted role in protein ectodomain sheddingInflamm Res, 51
B. Tian, J. Wen, Mei Zhang, D. Xie, R. Xu, C. Luo (2002)
The expression of ADAM12 (meltrin α) in human giant cell tumours of boneMolecular Pathology, 55
Hélène Cousin, Alban Gaultier, Christian Bleux, T. Darribère, D. Alfandari (2000)
PACSIN2 is a regulator of the metalloprotease/disintegrin ADAM13.Developmental biology, 227 1
B. Böhm, T. Aigner, A. Gehrsitz, C. Blobel, J. Kalden, H. Burkhardt (1999)
Up-regulation of MDC15 (metargidin) messenger RNA in human osteoarthritic cartilage.Arthritis and rheumatism, 42 9
F. Bosse, Gabor Petzold, Regine Greiner‐Petter, Ulrich Pippirs, C. Gillen, H. Müller (2000)
Cellular localization of the disintegrin CRII‐7/rMDC15 mRNA in rat PNS and CNS and regulated expression in postnatal development and after nerve injuryGlia, 32
K. Iba, R. Albrechtsen, B. Gilpin, Camilla Fröhlich, F. Loechel, A. Zolkiewska, K. Ishiguro, T. Kojima, Wei Liu, J. Langford, Ralph Sanderson, C. Brakebusch, R. Fässler, U. Wewer (2000)
The Cysteine-Rich Domain of Human Adam 12 Supports Cell Adhesion through Syndecans and Triggers Signaling Events That Lead to β1 Integrin–Dependent Cell SpreadingThe Journal of Cell Biology, 149
Gesela Weskamp, Jörn Krätzschmar, Martha Reid, Carl Blobel (1996)
MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domainsThe Journal of Cell Biology, 132
M. Tanner, M. Tirkkonen, A. Kallioniemi, J. Isola, T. Kuukasjärvi, Colin Collins, Colin Collins, David Kowbel, David Kowbel, Xinxin Guan, Jeffrey Trent, J. Gray, Joe Gray, P. Meltzer, Olli Kallioniemi (1996)
Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.Cancer research, 56 15
K. Iba, R. Albrechtsen, B. Gilpin, F. Loechel, U. Wewer (1999)
Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion.The American journal of pathology, 154 5
E. Kriventseva, I. Koch, R. Apweiler, M. Vingron, P. Bork, M. Gelfand, S. Sunyaev (2003)
Increase of functional diversity by alternative splicing.Trends in genetics : TIG, 19 3
Qing Kang, Yi-Chun Cao, A. Zolkiewska (2000)
Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells.The Biochemical journal, 352 Pt 3
D. McCulloch, M. Harvey, A. Herington (2000)
The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosteroneMolecular and Cellular Endocrinology, 167
E. Stickeler, F. Kittrell, D. Medina, S. Berget (1999)
Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesisOncogene, 18
Erxi Wu, Peter Croucher, N. Mckie (1997)
Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies.Biochemical and biophysical research communications, 235 2
J. Becherer, Carl Blobel (2003)
Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs).Current topics in developmental biology, 54
F. Peiretti, Paule Deprez‐Beauclair, B. Bonardo, Hélène Aubert, I. Juhan-vague, G. Nalbone (2003)
Identification of SAP97 as an intracellular binding partner of TACEJournal of Cell Science, 116
S. Gendler, E. Cohen, Ann Craston, T. Duhig, G. Johnstone, D. Barnes (1990)
The locus of the polymorphic epithelial mucin (PEM) tumour antigen on chromosome 1q21 shows a high frequency of alteration in primary human breast tumoursInternational Journal of Cancer, 45
J. Gee, J. Knowlden (2003)
ADAM metalloproteases and EGFR signallingBreast Cancer Research : BCR, 5
T. Yoshimura, T. Tomita, M. Dixon, A. Axon, P. Robinson, J. Crabtree (2002)
ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa.The Journal of infectious diseases, 185 3
A. Gschwind, S. Hart, O. Fischer, A. Ullrich (2003)
TACE cleavage of proamphiregulin regulates GPCR‐induced proliferation and motility of cancer cellsThe EMBO Journal, 22
L. Howard, K. Nelson, R. Maciewicz, C. Blobel (1999)
Interaction of the Metalloprotease Disintegrins MDC9 and MDC15 with Two SH3 Domain-containing Proteins, Endophilin I and SH3PX1*The Journal of Biological Chemistry, 274
Cao (2001)
Metalloprotease-disintegrin ADAM 12 interacts with alpha-actinin-1Biochem J, 357
S. Mori, Motonari Tanaka, D. Nanba, E. Nishiwaki, H. Ishiguro, S. Higashiyama, N. Matsuura (2003)
PACSIN3 Binds ADAM12/Meltrin α and Up-regulates Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor*Journal of Biological Chemistry, 278
C. Abram, D. Seals, I. Pass, Daniel Salinsky, L. Maurer, Therese Roth, S. Courtneidge (2003)
The Adaptor Protein Fish Associates with Members of the ADAMs Family and Localizes to Podosomes of Src-transformed Cells*The Journal of Biological Chemistry, 278
B. Böhm, T. Aigner, C. Blobel, J. Kalden, H. Burkhardt (2001)
Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue.Arthritis and rheumatism, 44 9
Y. Cao, Q. Kang, A. Zolkiewska (2001)
Metalloprotease-disintegrin ADAM 12 interacts with alpha-actinin-1.The Biochemical journal, 357 Pt 2
A. Forus, A. D'Angelo, J. Henriksen, G. Merla, G. Maelandsmo, V. Flørenes, S. Olivieri, B. Bjerkehagen, L. Meza-Zepeda, F. Blanco, Christoph Müller, F. Sanvito, J. Kononen, J. Nesland, Ø. Fodstad, A. Reymond, O. Kallioniemi, G. Arrigoni, A. Ballabio, O. Myklebost, M. Zollo (2001)
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas–a possible mechanism for altering the nm23-H1 activityOncogene, 20
M. Emi, T. Katagiri, Y. Harada, H. Saito, J. Inazawa, I. Ito, F. Kasumi, Yusuke Nakamura (1993)
A novel metalloprotease/disintegrin–like gene at 17q21.3 is somatically rearranged in two primary breast cancersNature Genetics, 5
Barbara Herren, K. Garton, Scott Coats, D. Bowen-Pope, R. Ross, E. Raines (2001)
ADAM15 overexpression in NIH3T3 cells enhances cell-cell interactions.Experimental cell research, 271 1
B. Tian, J. Wen, M. Zhang, D. Xie, R. Xu, C. Luo (2002)
The expression of ADAM12 (meltrin alpha) in human giant cell tumours of bone.Molecular pathology : MP, 55 6
H. Cooke (1979)
Cloning of human satellite III DNA: different components are on different chromosomes.Nucleic acids research, 6 10
Li Huang, Libing Feng, Limin Yang, Weiguo Zhou, Shouyuan Zhao, Changben Li (2004)
Screen and identification of proteins interacting with ADAM19 cytoplasmic tailMolecular Biology Reports, 29
T. Orbán, E. Oláh (2003)
Emerging roles of BRCA1 alternative splicingMolecular Pathology, 56
Qing Kang, Yi-Chun Cao, A. Zolkiewska (2001)
Direct Interaction between the Cytoplasmic Tail of ADAM 12 and the Src Homology 3 Domain of p85α Activates Phosphatidylinositol 3-Kinase in C2C12 Cells*The Journal of Biological Chemistry, 276
Pengcheng Zhu, Yubo Sun, R. Xu, Y. Sang, Jing Zhao, Gang Liu, Liang Cai, Changben Li, Shouyuan Zhao (2003)
The interaction between ADAM 22 and 14-3-3zeta: regulation of cell adhesion and spreading.Biochemical and biophysical research communications, 301 4
M. Arndt, U. Lendeckel, C. Röcken, Karen Nepple, C. Wolke, A. Spiess, C. Huth, S. Ansorge, H. Klein, A. Goette (2002)
Altered Expression of ADAMs (A D isintegrin A nd M etalloproteinase) in Fibrillating Human AtriaCirculation: Journal of the American Heart Association, 105
P. Gutwein, M. Oleszewski, S. Mechtersheimer, N. Agmon-Levin, Kerstin Krauss, P. Altevogt (2000)
Role of Src Kinases in the ADAM-mediated Release of L1 Adhesion Molecule from Human Tumor Cells*The Journal of Biological Chemistry, 275
Zhining Wang, H. Lo, Howard Yang, Sheryl Gere, Ying Hu, K. Buetow, M. Lee (2003)
Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer.Cancer research, 63 3
John Martin, Lisa Eynstone, M. Davies, John Williams, R. Steadman (2002)
The Role of ADAM 15 in Glomerular Mesangial Cell Migration*The Journal of Biological Chemistry, 277
K. Nelson, J. Schlöndorff, C. Blobel (1999)
Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta.The Biochemical journal, 343 Pt 3
ADAM genes have been associated with cancer, with ADAM expression, genomic rearrangements, and, by implication of ADAM proteins in the altered behavior found in tumor cells. In the present study, increased copy number of the ADAM15 gene in human breast cancer cell lines was demonstrated by fluorescence in situ hybridization. This was not reflected in mRNA levels, however. Instead, the use of alternative ADAM15 exons appeared erratic, leading to aberrant combinations of ADAM15 mRNA isoforms in the cancer cells. Clustering analysis indicated that these isoform patterns were nonrandom, suggesting a failure in the regulation mechanism or mechanisms of the alternative exon usage. Altered regulation of alternative exon usage may provide a useful target for cancer diagnostics development. ADAM15 would be particularly appropriate for breast cancer diagnostics because the various combinations of its three alternatively used exons can be readily examined with a simple, straightforward PCR protocol. © 2004 Wiley‐Liss, Inc.
Genes, Chromosomes and Cancer – Wiley
Published: Dec 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.